El Khoury, Petra <br/><br/>
Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.  [electronic resource] 

 -  Diabetes, obesity & metabolism  04 2018 
 - 943-953 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.13181  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Cardiovascular Diseases--blood<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Angiopathies--blood<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Proprotein Convertase 9--blood<br/>Risk Factors